Buena, NJ (PRWEB) July 10, 2013
Comar is leading the way in developing SecureCap™ Child-Resistant (CR) Closures in response to the Consumer Product Safety Commission (CPSC) rule requiring child-resistant (CR) packaging for products containing the equivalent of 0.08 milligrams or more of “imidazoline.”
The SecureCap™ Child-Resistant Closures utilize Comar's existing two-piece push and turn technology with proven CR and SF (senior friendly) effectiveness.
The technology is a natural progression for Comar and comprised of a two component system (inner and outer) originally designed and utilized in the market for our dropper assemblies. The CR dropper caps are currently standard stocked items in 20mm, 24mm and 28mm sizes.
CPSC mini protocol tests were completed with positive results in mid-May 2013 with a full protocol to follow, and commercialization expected later this year.
Sizes ranging from 13mm-15mm for ophthalmic and 15mm-18mm for nasal will be offered and various sample sizes are now available.
SecureCap™ Child-Resistant (CR) Closures are patent pending and will be CE marked. System components are manufactured in facilities that comply with current Good Manufacturing Practices (cGMP) and ISO 9001:13485 quality standards. Comar provides manufacturing services for pharmaceutical and Class 1 medical device molding. For additional information, please call Comar toll free at 1-800-962-6627; international callers, please dial 1-856-692-6100.
Comar, Inc. is a market leading designer and manufacturer of innovative packaging solutions and liquid dispensing products, serving the pharmaceutical, diagnostic, health, and personal care markets. The company is devoted to safely and accurately delivering medications to everyone, and currently has manufacturing locations in the U.S. and Puerto Rico. For more information please visit http://www.comar.com.